MedPath

TANTA UNIVERSITY

TANTA UNIVERSITY logo
🇪🇬Egypt
Ownership
Private
Established
1972-01-01
Employees
1K
Market Cap
-
Website
http://www.tanta.edu.eg

Clinical Trials

808

Active:20
Completed:408

Trial Phases

6 Phases

Early Phase 1:16
Phase 1:23
Phase 2:75
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (696 trials with phase data)• Click on a phase to view related trials

Not Applicable
456 (65.5%)
Phase 2
75 (10.8%)
Phase 4
65 (9.3%)
Phase 3
61 (8.8%)
Phase 1
23 (3.3%)
Early Phase 1
16 (2.3%)

Transversalis Fascia Plane Block Versus Intrathecal Dexmedetomidine in Patients Undergoing Cesarean Section

Not Applicable
Not yet recruiting
Conditions
Transversalis Fascia Plane Block
Intrathecal Dexmedetomidine
Cesarean Section
Interventions
Other: Transversalis fascia plane block
First Posted Date
2025-09-12
Last Posted Date
2025-09-12
Lead Sponsor
Tanta University
Target Recruit Count
50
Registration Number
NCT07170267
Locations
🇪🇬

Tanta University, Tanta, El-Gharbia, Egypt

Lung Ultrasound Versus Inferior Vena Cava Collapsibility Index for Early Prediction of Volume Overload During Transurethral Resection of Prostate

Not Applicable
Conditions
Lung Ultrasound Score
Transurethral Resection (TUR) Syndrome
Prostate
First Posted Date
2025-09-10
Last Posted Date
2025-09-10
Lead Sponsor
Tanta University
Target Recruit Count
60
Registration Number
NCT07164638
Locations
🇪🇬

Tanta University, Tanta, Egypt

Do Increasing Preoperative Timing of Single Dexmedetomidine Dose Have an Effect on Stress Response of Laryngoscopy and Intubation?

Not Applicable
Recruiting
Conditions
Time
Stress Response
Intubation
Dexmedetomidine
Laryngoscopy
Interventions
First Posted Date
2025-09-10
Last Posted Date
2025-09-12
Lead Sponsor
Tanta University
Target Recruit Count
45
Registration Number
NCT07165483
Locations
🇪🇬

Tanta University, Tanta, El-Gharbia, Egypt

Potassium-Competitive Acid Blocker Versus Proton Pump Inhibitor as A Part of Bismuth Based Quadruple Therapy for Treatment of Helicobacter Pylori Infection

Not Applicable
Recruiting
Conditions
Potassium-Competitive Acid Blocker
Proton Pump Inhibitor
Bismuth Based Quadruple Therapy
Treatment
Helicobacter Pylori Infection
Interventions
Drug: Potassium-Competitive Acid Blocker
Drug: Proton Pump Inhibitor
First Posted Date
2025-09-10
Last Posted Date
2025-09-12
Lead Sponsor
Tanta University
Target Recruit Count
320
Registration Number
NCT07165444
Locations
🇪🇬

Tanta University, Tanta, El-Gharbia, Egypt

Prefabricated CAD CAM Allogeneic Ring Blocks in the Anterior Maxilla With Immediate Implantation

Not Applicable
Completed
Conditions
Prefabricated
Immediate Implantation
CAD
Anterior Maxilla
CAM
Allogeneic Ring Blocks
First Posted Date
2025-09-09
Last Posted Date
2025-09-09
Lead Sponsor
Tanta University
Target Recruit Count
20
Registration Number
NCT07163351
Locations
🇪🇬

Cairo University, Cairo, Egypt

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 155
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.